CS
DMTK

Credit Suisse’s DermTech, Inc. Common Stock DMTK Stock Holding History

Credit Suisse’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,320
Closed -$41K – 4169
2022
Q3 		$41K Sell
10,320
-8
-0.1% -$49 ﹤0.01% 3549
2022
Q2 		$57K Sell
10,328
-2,008
-16% -$16.4K ﹤0.01% 3620
2022
Q1 		$181K Sell
12,336
-94,989
-89% -$1.27M ﹤0.01% 3397
2021
Q4 		$1.7M Buy
107,325
+8,677
+9% +$208K ﹤0.01% 2911
2021
Q3 		$3.17M Sell
98,648
-12,401
-11% -$436K ﹤0.01% 2437
2021
Q2 		$4.62M Buy
111,049
+18,172
+20% +$746K ﹤0.01% 2150
2021
Q1 		$4.72M Buy
92,877
+1,140
+1% +$59.6K ﹤0.01% 2110
2020
Q4 		$2.98M Buy
+91,737
New +$1.3M ﹤0.01% 2532

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EP
EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse's DMTK Position: Q4 2022 in Review

Credit Suisse sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 10,320 shares — an estimated $41K sold.

Credit Suisse first reported a position in DMTK in Q4 2020 and held it in 8 quarters. The position peaked at $4.72M in Q1 2021. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

  • Credit Suisse reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Credit Suisse sold 10,320 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $41K.
  • Credit Suisse first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Credit Suisse's DermTech, Inc. Common Stock position peaked at $4.72M in Q1 2021.
  • 94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on Credit Suisse's 13F filing for Q4 2022, filed 13 Feb 2023.